Cargando…
Antisense oligonucleotides in neurological disorders
The introduction of genetics revolutionized the field of neurodegenerative and neuromuscular diseases and has provided considerable insight into the underlying pathomechanisms. Nevertheless, effective treatment options have been limited. This changed recently when antisense oligonucleotides (ASOs) c...
Autores principales: | Wurster, Claudia D., Ludolph, Albert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971383/ https://www.ncbi.nlm.nih.gov/pubmed/29854003 http://dx.doi.org/10.1177/1756286418776932 |
Ejemplares similares
-
Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology
por: Amanat, Man, et al.
Publicado: (2022) -
Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019) -
Silencing Antibiotic Resistance with Antisense Oligonucleotides
por: Jani, Saumya, et al.
Publicado: (2021) -
Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023) -
Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016)